JPMA Position Statements
JPMA is committed to contributing to the better health of patients worldwide through the promotion of drug discovery, research and development. In support of such research and to ensure that the resulting medicines safely reach the patients that need them, the JPMA has shared statements in the The JPMA has shared statements in the following areas: The Japanese Pharmaceutical Manufacturers Association (JPMA)
Delivering equitable access in pandemics: Biopharmaceutical industry commitments
In response to the threat of future global pandemics, the Japanese Pharmaceutical Manufacturers Association (JPMA), in collaboration with the In response to the threat of future global pandemics, the Japanese Pharmaceutical Manufacturers Association (JPMA), in collaboration with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and six other organizations, developed a set of commitments for Please click here to read more.
Proposals from the Pharmaceutical Industry for the G7 Hiroshima Summit Health Agenda: Joint
The Japanese Pharmaceutical Manufacturers Association (JPMA) and the International Federation of Pharmaceutical Manufacturers and Associations ( IFPMA) jointly submitted the "Proposals from the Pharmaceutical Industry for the G7 Hiroshima Summit Health Agenda" to the Prime Minister, Minister of Health, Labor and Welfare, Minister of Finance, and Minister of Foreign Affairs. Please click here Please click here.
Joint IFPMA-JPMA-PhRMA Letter for G20 Japan-Saudi transition: Recommendations from Pharmaceutical Industry for G20 Health Ministers
JPMA submitted "Joint IFPMA-JPMA-PhRMA Letter for G20 Japan-Saudi transition" to both of the Ministers of Foreign Affairs and Ministers of Health. Please click here to read more. Please click here Please click here.
Recommendations from the Pharmaceutical Industry for the G20 Health Ministers Meeting: Joint
JPMA submitted "Recommendations from Pharmaceutical Industry for G20 Health Ministers Meeting" to the Minister of Health, Labour and Please click here to read more. Please click here Please click here to read more.
Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda: Joint
JPMA submitted "Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda" to the Prime Minister of Japan, the JPMA submitted "Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda" to the Prime Minister of Japan, the Minister of Health, Labour and Welfare, the Minister of Finance and the Minister for Foreign Affairs. Please click below to learn more about JPMA's recommendations.
- Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda to the Prime Minister (132KB)
- Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda to the Minister of Health, Labour and Welfare(132KB)
- Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda to the Minister of Finance(132KB)
- Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda to the Minister for Foreign Affairs(132KB)
JPMA's Activities for Access to Medicines in Developing Countries: Recommendations from the JPMA
The United Nations High-Level Panel on Access to Medicines issued a report on September 14, 2016. JPMA recognizes that there are multi-layered It requires a solution with a holistic approach. Please click here Please click here to read more.
JPMA recommendations for G7 Health Minister's Meeting: Recommendations from the pharmaceutical industry for the G20 Osaka Summit
JPMA submitted "recommendations for G7 Health Minister's Meeting" to the Minister of Health, Labour and Welfare on July 26, 2016. Please click here to learn more about JPMA's proposals.
G7 Ise-Shima Summit: Counterfeit Medicines
JPMA submitted "Requests for the Health Agendas at the G7 Ise-Shima Summit" to the Minister of Health, Labour and Welfare in April 2016. click here to learn more about JPMA's proposals.
Counterfeit Medicines: JPMA recommendations for G7 Health Minister's Meeting: G7 Ise-Shima Summit
We work to protect patients from the dangers of counterfeit medicines that are presented as genuine and approved products. Please click here Please click here to learn more about JPMA's proposals.
Intellectual Property Rights: Intellectual Property Rights: Intellectual Property Rights: Intellectual Property Rights: Intellectual Property Rights
We promote understanding of the important role of intellectual property rights in enabling drug discovery, research and development for new medicines while also creating access to such medicines. We promote understanding of the important role of intellectual property rights in enabling drug discovery, research and development for new medicines while also creating access to such medicines. click here Please click here to learn more about JPMA's proposals.
Universal Health Coverage
We are engaged in the ongoing discussion regarding the Post-2015 United Nations sustainable development goals and sees universal health coverage as a We are engaged in the ongoing discussion regarding the Post-2015 United Nations sustainable development goals and sees universal health coverage as a key contributor to the wealth and economic productivity of countries. click here Please click here to learn more about JPMA's proposals.